• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病患者健康相关生活质量和心理困扰的性别差异:合并症有影响吗?欧洲心脏病学会(ESC)欧洲动脉粥样硬化患病率和干预效果研究(EUROASPIRE)V注册研究结果

Gender differences in health-related quality of life and psychological distress among coronary patients: Does comorbidity matter? Results from the ESC EORP EUROASPIRE V registry.

作者信息

Vynckier Pieter, Van Wilder Lisa, Kotseva Kornelia, Wood David, Gevaert Sofie, Clays Els, De Bacquer Dirk, De Smedt Delphine

机构信息

Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

出版信息

Int J Cardiol. 2023 Jan 15;371:452-459. doi: 10.1016/j.ijcard.2022.09.010. Epub 2022 Sep 8.

DOI:10.1016/j.ijcard.2022.09.010
PMID:36087631
Abstract

AIMS

This study aimed to provide an overview on contemporary gender differences in HRQoL/psychological distress and their relationship with comorbidity burden among European coronary heart disease (CHD) patients.

METHODS

Analyses were based on the cross-sectional ESC EORP EUROASPIRE V survey. Consecutive patients (aged 18-80 years), hospitalized for a first or recurrent coronary event were included in this study. Data at hospital discharge and at follow-up (6 to 24 months after hospitalisation) were collected.

RESULTS

Data were available for 8261 patients of which 25.8% women. Overall, women reported a worse EQ-5D-5L index score (0.73 vs. 0.81; P < 0.001), EQ-VAS (63.1 vs. 66.0; P = 0.001), global HeartQoL (1.94 vs. 2.26; P < 0.001), physical HeartQoL (1.96 vs. 2.30; P < 0.001), emotional HeartQoL (1.88 vs. 2.18; P < 0.001), HADS-A (6.69 vs. 4.99; P < 0.001), and HADS-D (5.73 vs. 4.62; P < 0.001) compared to men. Also, women were more likely to have comorbidities compared to men (1 comorbidity: 38.7% vs. 35.0%, 2 comorbidities: 9.7% vs. 7.5%; P < 0.001). There is indication that heart failure (EQ-VAS) and diabetes (global HeartQoL, emotional HeartQoL, physical HeartQoL, and HADS-D) interacted with gender and modulate the relationship with HRQoL, in disfavour of women.

CONCLUSION

Substantial gender-based health inequalities in terms of HRQoL and psychological distress were found, in disfavour of women. Women had worse HRQoL and psychological distress outcomes when having comorbidities. To a limited extent, comorbidity and women had a negative/synergistic effect on HRQoL. Special attention should be given to this population groups within daily clinical practice.

摘要

目的

本研究旨在概述欧洲冠心病(CHD)患者在健康相关生活质量/心理困扰方面的当代性别差异及其与合并症负担的关系。

方法

分析基于横断面的欧洲心脏病学会(ESC)欧洲动脉粥样硬化干预与研究项目(EUROASPIRE)V调查。本研究纳入了因首次或复发性冠状动脉事件住院的连续患者(年龄18 - 80岁)。收集了出院时及随访(住院后6至24个月)的数据。

结果

共有8261例患者的数据可用,其中女性占25.8%。总体而言,女性报告的EQ - 5D - 5L指数得分更低(0.73对0.81;P < 0.001),EQ视觉模拟量表(EQ - VAS)得分更低(63.1对66.0;P = 0.001),整体心脏生活质量(HeartQoL)得分更低(1.94对2.26;P < 0.001),身体方面的心脏生活质量得分更低(1.96对2.30;P < 0.001),情感方面的心脏生活质量得分更低(1.88对2.18;P < 0.001),医院焦虑抑郁量表(HADS - A)得分更高(6.69对4.99;P < 0.001),以及HADS - D得分更高(5.73对4.62;P < 0.001)。此外,与男性相比,女性更易患有合并症(一种合并症:38.7%对35.0%,两种合并症:9.7%对7.5%;P < 0.001)。有迹象表明,心力衰竭(EQ - VAS)和糖尿病(整体心脏生活质量、情感方面的心脏生活质量、身体方面的心脏生活质量以及HADS - D)与性别相互作用,并调节了与健康相关生活质量的关系,对女性不利。

结论

在健康相关生活质量和心理困扰方面发现了显著的基于性别的健康不平等,对女性不利。患有合并症时,女性的健康相关生活质量和心理困扰结果更差。在一定程度上,合并症和女性性别对健康相关生活质量有负面/协同作用。在日常临床实践中应特别关注这一人群。

相似文献

1
Gender differences in health-related quality of life and psychological distress among coronary patients: Does comorbidity matter? Results from the ESC EORP EUROASPIRE V registry.冠心病患者健康相关生活质量和心理困扰的性别差异:合并症有影响吗?欧洲心脏病学会(ESC)欧洲动脉粥样硬化患病率和干预效果研究(EUROASPIRE)V注册研究结果
Int J Cardiol. 2023 Jan 15;371:452-459. doi: 10.1016/j.ijcard.2022.09.010. Epub 2022 Sep 8.
2
Gender differences in patient-reported outcomes in patients with acute myocardial infarction.急性心肌梗死患者报告结局的性别差异。
Eur J Cardiovasc Nurs. 2022 Nov 23;21(8):772-781. doi: 10.1093/eurjcn/zvac022.
3
Polypharmacy and Health-Related Quality of Life/Psychological Distress Among Patients With Chronic Disease.慢性病患者的多病用药与健康相关生活质量/心理困扰。
Prev Chronic Dis. 2022 Aug 18;19:E50. doi: 10.5888/pcd19.220062.
4
The association between self-reported health status and adverse events: a comparison among coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI).自报健康状况与不良事件之间的关联:冠状动脉旁路移植术(CABG)与经皮冠状动脉介入治疗(PCI)的比较。
Qual Life Res. 2020 Nov;29(11):3017-3029. doi: 10.1007/s11136-020-02573-8. Epub 2020 Aug 28.
5
Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry.冠心病患者危险因素控制的性别差距远未缩小:来自欧洲心脏病学会 EUROASPIRE V 注册研究的结果。
Eur J Prev Cardiol. 2022 Mar 11;29(2):344-351. doi: 10.1093/eurjpc/zwaa144.
6
Validity and reliability of the HeartQoL questionnaire in a large sample of stable coronary patients: The EUROASPIRE IV Study of the European Society of Cardiology.心脏生活质量问卷在大量稳定型冠心病患者样本中的有效性和可靠性:欧洲心脏病学会的EUROASPIRE IV研究
Eur J Prev Cardiol. 2016 May;23(7):714-21. doi: 10.1177/2047487315604837. Epub 2015 Sep 10.
7
Gender differences in lifestyle management among coronary patients and the association with education and age: results from the ESC EORP EUROASPIRE V registry.冠心病患者生活方式管理中的性别差异及其与教育和年龄的关系:ESC EORP EUROASPIRE V 注册研究结果。
Eur J Cardiovasc Nurs. 2022 Oct 14;21(7):717-723. doi: 10.1093/eurjcn/zvab129.
8
Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry.性别差异与心血管风险因素认知:ESC EORP EUROASPIRE V 注册研究结果。
Int J Cardiol. 2022 Apr 1;352:152-157. doi: 10.1016/j.ijcard.2022.01.059. Epub 2022 Feb 3.
9
Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry.冠心病患者的治疗:是否仍存在性别差距?来自欧洲心脏病学会 EUROASPIRE V 注册研究的结果。
Cardiovasc Drugs Ther. 2021 Aug;35(4):801-808. doi: 10.1007/s10557-020-07095-6. Epub 2020 Oct 17.
10
EQ-5D in coronary patients: what are they suffering from? Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry.EQ-5D 在冠心病患者中的应用:患者的痛苦究竟源自何方?ESC EORP 欧洲心血管疾病预防和糖尿病调查(EUROASPIRE IV)注册研究结果。
Qual Life Res. 2020 Apr;29(4):1037-1046. doi: 10.1007/s11136-019-02334-2. Epub 2019 Nov 18.

引用本文的文献

1
Do the Gender and the Number of Comorbidities and the Use of Tertiary Prevention Play a Role in the Severity of Anxiety and Depression in Patients with Coronary Artery Disease? A POLASPIRE II Study.性别、合并症数量及三级预防的使用在冠状动脉疾病患者焦虑和抑郁严重程度中起作用吗?一项POLASPIRE II研究。
J Clin Med. 2024 Jun 28;13(13):3812. doi: 10.3390/jcm13133812.